--- title: Differential ion mobility interface enhances qualitative and quantitative mass spectral workflows description: The Thermo Scientific FAIMS Pro Duo interface builds upon the foundation of the Thermo Scientific FAIMS Pro interface to continue to support biological mass spectrometry (MS). image: https://news.lifesciencenewswire.com/hubfs/Thermo%20Scientific%20FAIMS%20Pro%20Duo%20interface%20(with%20Thermo%20Scientific%20Orbitrap%20Exploris%20240%20MS).png --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Differential ion mobility interface enhances qualitative and quantitative mass spectral workflows](https://news.lifesciencenewswire.com/newsroom/differential-ion-mobility-interface-enhances-qualitative-and-quantitative-mass-spectral-workflows) June 7, 2021 *The Thermo Scientific FAIMS Pro Duo interface simplifies workflows and extends orthogonal selectivity for greater mass spectral performance* ![Thermo Scientific FAIMS Pro Duo interface (with Thermo Scientific Orbitrap Exploris 240 MS)](https://news.lifesciencenewswire.com/hs-fs/hubfs/Thermo%20Scientific%20FAIMS%20Pro%20Duo%20interface%20(with%20Thermo%20Scientific%20Orbitrap%20Exploris%20240%20MS).png?width=331&name=Thermo%20Scientific%20FAIMS%20Pro%20Duo%20interface%20(with%20Thermo%20Scientific%20Orbitrap%20Exploris%20240%20MS).png)Scientists in pharmaceutical, biopharmaceutical and clinical research laboratories can benefit from a differential ion mobility interface that increases productivity and data quality for qualitative and quantitative workflows. The [Thermo Scientific FAIMS Pro Duo interface](https://www.thermofisher.com/us/en/home/industrial/mass-spectrometry/liquid-chromatography-mass-spectrometry-lc-ms/lc-ms-accessories/field-asymmetric-ion-mobility-spectrometry-faims.html) builds upon the foundation of the Thermo Scientific FAIMS Pro interface to continue to support biological mass spectrometry (MS) and extend differential ion mobility to a broader range of applications including proteomics, plasma profiling, and targeted small-molecule quantitation. The new interface enhances signal-to-noise ratios and expands sample coverage, allowing users to explore complex samples with reduced matrix interference, and increase the breadth and depth of their analysis. Additionally, optimal performance across a wide range of chromatographic flow rates (100 nL/min to 1 mL/min) allows scientists to push the research boundaries in areas such as proteome coverage, quantitative analysis, and more recently, glycoproteomics, single-cell proteomics, and structural biology. By eliminating sample preparation steps and simplifying calibration, workflow efficiency is increased, meeting the needs of high-throughput laboratories. “Many current workflows require labor-intensive and time-consuming sample preparation to provide the necessary level of selectivity for meaningful results, impeding sample throughput,” said Iain Mylchreest, vice president, research and development, analytical instruments, Thermo Fisher Scientific. “The FAIMS Pro Duo interface enhances orthogonal selectivity and suppresses matrix interference to increase workflow productivity, even for complex samples, allowing researchers to focus on answering scientific questions and driving discovery forward.” Professor Jun Qu, department of pharmaceutical sciences, State University of New York (SUNY) Buffalo and chief scientist in bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences, said, “Contrary to common beliefs, the primary factor limiting the sensitivity of liquid chromatography (LC)-MS or LC-MS/MS targeted protein quantitation is the high interference rooted from numerous peptides in highly complicated digested samples, rather than MS signal strength. In this regard, the FAIMS Pro Duo interface provides orthogonal selectivity to effectively separate the target from chemical noise with high reproducibility and robustness. When coupled to trapping micro-LC-MS, it dramatically improves quantitative sensitivity – achieving an amazing 1-5 ng/mL limit of quantitation for large mAb molecules in plasma/tissue, without using antibody enrichment. Such a sensitive, high-throughput technique will make a significant impact on LC-MS based analyses of protein drugs and biomarkers for pharmacokinetic studies.” The FAIMS Pro Duo interface easily integrates with Thermo Fisher’s next-generation mass spectrometers, including the [Thermo Scientific Orbitrap Tribrid mass spectrometers](http://www.thermofisher.com/Tribrid), [Thermo Scientific Orbitrap Exploris mass spectrometers](https://www.thermofisher.com/uk/en/home/industrial/mass-spectrometry/liquid-chromatography-mass-spectrometry-lc-ms/lc-ms-systems/orbitrap-lc-ms/orbitrap-exploris-mass-spectrometers.html), [Thermo Scientific TSQ Altis triple quadrupole mass spectrometer](https://www.thermofisher.com/uk/en/home/industrial/mass-spectrometry/liquid-chromatography-mass-spectrometry-lc-ms/lc-ms-systems/triple-quadrupole-lc-ms/tsq-altis-triple-quadrupole-ms.html) and [Thermo Scientific TSQ Quantis triple quadrupole mass spectrometer](https://www.thermofisher.com/uk/en/home/industrial/mass-spectrometry/liquid-chromatography-mass-spectrometry-lc-ms/lc-ms-systems/triple-quadrupole-lc-ms/tsq-quantis-triple-quadrupole-ms.html?gclid=Cj0KCQjws-OEBhCkARIsAPhOkIbX2j8Vt9YwcaOuiOW1AhqB-X4GOvAsJaPXa7Cq4W5yxa3YZ9j3ucEaAmNMEALw_wcB&ce=E.21CMD.DL107.39848.01&cid=E.21CMD.DL107.39848.01&ef_id=Cj0KCQjws-OEBhCkARIsAPhOkIbX2j8Vt9YwcaOuiOW1AhqB-X4GOvAsJaPXa7Cq4W5yxa3YZ9j3ucEaAmNMEALw_wcB:G:s&s_kwcid=AL!3652!3!249703668959!e!!g!!tsq%20quantis). To find out more about the Thermo Scientific FAIMS Pro Duo interface, please visit [www.thermofisher.com/FAIMSProDuo](http://www.thermofisher.com/FAIMSProDuo). Thermo Fisher Scientific will showcase its newest products, software solutions and collaborations in a company-hosted virtual event, “Innovation Summit: Shaping the Future of LC-MS in Life Science Together,” from June 8-10, 2021. Register [here](https://www.labroots.com/virtual-event/lcms-virtual-event) to learn more. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Analytical Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)